Veloxis Pharmaceuticals
Veloxis Pharmaceuticals A/S, formerly LifeCycle Pharma A/S, develops improved versions of difficult-to-formulate drugs with its proprietary drug formulation technology, called MeltDose®. Veloxis is focused on building a clinical and market-stage pharmaceutical business around its late-stage transplant immunosuppression product candidate LCP-Tacro. The company was founded in 2002 as a spin-off from H. Lundbeck A/S. Veloxis is headquartered in Horsholm, Denmark, with an office in Edison, New Jersey.
primaryTopic
Veloxis Pharmaceuticals
Veloxis Pharmaceuticals A/S, formerly LifeCycle Pharma A/S, develops improved versions of difficult-to-formulate drugs with its proprietary drug formulation technology, called MeltDose®. Veloxis is focused on building a clinical and market-stage pharmaceutical business around its late-stage transplant immunosuppression product candidate LCP-Tacro. The company was founded in 2002 as a spin-off from H. Lundbeck A/S. Veloxis is headquartered in Horsholm, Denmark, with an office in Edison, New Jersey.
has abstract
Veloxis Pharmaceuticals A/S, f ...... office in Edison, New Jersey.
@en
industry
location
number of employees
type
Link from a Wikipage to an external page
Wikipage page ID
33,185,928
Wikipage revision ID
676,725,095
key people
William J. Polvino, M.D. , Kim Bjørnstrup
products
Orally-delivered pharmaceuticals
subject
comment
Veloxis Pharmaceuticals A/S, f ...... office in Edison, New Jersey.
@en
label
Veloxis Pharmaceuticals
@en
wasDerivedFrom
homepage
isPrimaryTopicOf
name
Veloxis Pharmaceuticals
@en